Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated meaningful weight loss effects in clinical trials. When used for weight management, semaglutide works by signaling fullness to your brain, reducing food cravings, and slowing how quickly your stomach empties. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies across all 50 states, with pricing that stays flat as your dose increases.

How Semaglutide Supports Weight Loss

Semaglutide binds to GLP-1 receptors scattered throughout your brain, particularly in areas controlling appetite and satiety. Once activated, these receptors send signals that make you feel full with smaller meals and reduce the constant drive to eat between meals. The medication also slows gastric emptying—meaning food stays in your stomach longer—which extends the sensation of fullness for hours after eating. In clinical studies, patients using semaglutide for weight management lost an average of 15% of their body weight over 68 weeks when combined with structured eating and activity changes.

Beyond appetite control, semaglutide influences how your body processes energy and stores fat. GLP-1 signaling can increase insulin secretion when blood sugar rises, helping maintain stable glucose levels throughout the day. This metabolic support reduces energy crashes and the compensatory hunger that often follows blood sugar dips. Your liver and pancreas both express GLP-1 receptors, meaning semaglutide's effects extend throughout multiple body systems rather than working through a single mechanism. This multi-system action helps explain why semaglutide produces more sustained weight loss compared to older appetite-suppressing drugs that relied on central nervous system stimulation alone.

Semaglutide Injection vs. Oral Formulations

Semaglutide injections deliver the medication directly into fatty tissue under the skin, bypassing stomach acid that would break down the peptide if swallowed. This route allows for once-weekly dosing and generally produces higher blood levels of active medication, often making injectable semaglutide more potent for weight loss. PlexusDx compounded semaglutide injections start at $149 per month with no flat per-compound pricing increases as your provider adjusts your dose upward. Patients often report clearer dose titration and faster results with the injectable form, though some prefer the convenience of daily oral medication.

Oral semaglutide is taken as a tablet and uses special formulation technology to protect the peptide from stomach acid while enhancing absorption through the small intestine. Oral semaglutide requires an empty stomach and specific timing to maximize effectiveness, and blood levels typically remain lower than injectable versions. PlexusDx offers compounded oral semaglutide starting at $249 per month, providing flexibility for patients who prefer swallowing a pill over self-injection. Both forms are HSA/FSA eligible and require no insurance, with your price remaining constant regardless of dose strength.

Understanding Your Genetic Response to Semaglutide

Your genetic makeup influences how strongly your GLP-1 receptors respond to semaglutide and how efficiently your body processes the medication. The GLP1R gene contains variants that can affect receptor sensitivity—for example, individuals carrying certain alleles at position rs6923761 may experience different appetite suppression intensity compared to others. Similarly, genetic differences in the FTO gene (associated with metabolic rate) and MC4R gene (involved in energy expenditure) shape how your body burns calories while taking semaglutide. PlexusDx Precision Peptide Genetic Test analyzes these and 46 additional peptide-pathway genes to predict your individual response pattern.

Armed with your genetic insights, PlexusDx providers can personalize your starting dose, titration schedule, and even compound selection based on which medication aligns best with your body's biological profile. Some patients with specific GIPR or GLP1R variants may benefit from PlexusDx GLP-Squared dual-compound therapy (semaglutide plus tirzepatide) rather than semaglutide alone. The genetic test costs $99 as an add-on after your first month of treatment and maps 14 metabolic pathways, 49 peptides, and 150+ clinical insights specific to weight loss. This precision approach transforms weight loss therapy from one-size-fits-all to truly personalized medicine.

Starting Semaglutide at PlexusDx: What to Expect

PlexusDx serves all 50 states with no insurance requirement, membership fee, or prior authorization hassle. Your initial consultation includes a detailed health history, current medications, and metabolic goals—all conducted online for convenience. Once approved by a licensed provider, compounded semaglutide from licensed 503A pharmacies ships directly to your home within 5–7 business days. Your provider creates a personalized dose escalation plan, typically starting at a lower dose and increasing every 1–2 weeks to minimize nausea and other adjustment effects while your body adapts.

Most patients begin with a 0.25 mg weekly injection dose or a 3 mg daily oral dose, depending on their medical history and provider recommendation. Over 4–8 weeks, doses gradually increase toward therapeutic levels (typically 2.4 mg weekly for injections, 14 mg daily for oral). PlexusDx emphasizes that your dose may need to go up, but your price won't—all semaglutide injection formulations cost $149–$189 per month across different commitment tiers, regardless of dose strength. Regular follow-up appointments via telemedicine track your progress, address side effects, and adjust your plan as needed. HSA and FSA accounts cover PlexusDx semaglutide, reducing out-of-pocket costs for eligible patients.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide from PlexusDx the same as brand-name Ozempic or Wegovy?

PlexusDx semaglutide is compounded from bulk pharmaceutical-grade semaglutide by licensed 503A pharmacies, not manufactured by Novo Nordisk. The active ingredient is identical to brand products, but compounding allows for flexible dosing and lower costs. Compounded semaglutide is not FDA-approved as a finished drug product, though the base ingredient meets pharmaceutical standards.

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 15–22% of body weight over 68 weeks when semaglutide is combined with diet and physical activity. Individual results vary significantly based on genetics, adherence, diet quality, and exercise habits. PlexusDx Precision Peptide Genetic Testing can help predict your likely response pattern, allowing your provider to tailor your treatment approach from the start.

What does semaglutide cost at PlexusDx?

Compounded semaglutide injections start at $149 per month and oral semaglutide starts at $249 per month. Your monthly price remains constant—no hidden per-dose increases as your provider adjusts your dose strength. Both formulations are HSA/FSA eligible and available in all 50 states without insurance.

What side effects should I expect from semaglutide?

The most common side effects during dose escalation are nausea, vomiting, constipation, and mild abdominal discomfort, typically improving within days to weeks as your body adjusts. Serious side effects are rare but can include pancreatitis, gallbladder issues, and rapid heart rate—all require immediate medical attention. PlexusDx providers monitor your response closely and can adjust your dose or switch you to an alternative peptide therapy if side effects persist.

Can genetic testing predict how well semaglutide will work for me?

Yes. PlexusDx Precision Peptide Genetic Test examines your GLP1R, GIPR, FTO, and MC4R variants—all tied to semaglutide response and weight loss potential. The test costs $99 (added after your first month) and maps 14 pathways to predict your individual peptide sensitivity, helping your provider optimize your dose, formulation, and long-term strategy.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves